12:00 AM
Oct 21, 2013
 |  BC Week In Review  |  Company News  |  Other News

Kymab, Regeneron antibodies news

Kymab said it notified the English Court that it will defend against claims by Regeneron that Kymab has infringed Regeneron's European patent EP1360287 covering methods...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >